Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21358214

Download in:

View as

General Info

PMID
21358214